406 related articles for article (PubMed ID: 30654773)
1. The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data.
Alammar N; Wang L; Saberi B; Nanavati J; Holtmann G; Shinohara RT; Mullin GE
BMC Complement Altern Med; 2019 Jan; 19(1):21. PubMed ID: 30654773
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.
Black CJ; Yuan Y; Selinger CP; Camilleri M; Quigley EMM; Moayyedi P; Ford AC
Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):117-131. PubMed ID: 31859183
[TBL] [Abstract][Full Text] [Related]
3. Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis.
Khanna R; MacDonald JK; Levesque BG
J Clin Gastroenterol; 2014 Jul; 48(6):505-12. PubMed ID: 24100754
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
Rahimi R; Nikfar S; Abdollahi M
Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
[TBL] [Abstract][Full Text] [Related]
5. Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome.
Ingrosso MR; Ianiro G; Nee J; Lembo AJ; Moayyedi P; Black CJ; Ford AC
Aliment Pharmacol Ther; 2022 Sep; 56(6):932-941. PubMed ID: 35942669
[TBL] [Abstract][Full Text] [Related]
6. A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms.
Cash BD; Epstein MS; Shah SM
Dig Dis Sci; 2016 Feb; 61(2):560-71. PubMed ID: 26319955
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.
Weerts ZZRM; Masclee AAM; Witteman BJM; Clemens CHM; Winkens B; Brouwers JRBJ; Frijlink HW; Muris JWM; De Wit NJ; Essers BAB; Tack J; Snijkers JTW; Bours AMH; de Ruiter-van der Ploeg AS; Jonkers DMAE; Keszthelyi D
Gastroenterology; 2020 Jan; 158(1):123-136. PubMed ID: 31470006
[TBL] [Abstract][Full Text] [Related]
8. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome.
Quartero AO; Meineche-Schmidt V; Muris J; Rubin G; de Wit N
Cochrane Database Syst Rev; 2005 Apr; (2):CD003460. PubMed ID: 15846668
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.
Zheng Y; Yu T; Tang Y; Xiong W; Shen X; Jiang L; Lin L
PLoS One; 2017; 12(3):e0172846. PubMed ID: 28291778
[TBL] [Abstract][Full Text] [Related]
10. Tegaserod for the treatment of irritable bowel syndrome.
Evans BW; Clark WK; Moore DJ; Whorwell PJ
Cochrane Database Syst Rev; 2004; (1):CD003960. PubMed ID: 14974049
[TBL] [Abstract][Full Text] [Related]
11. Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials.
Qi Q; Zhang Y; Chen F; Zuo X; Li Y
BMC Gastroenterol; 2018 Jan; 18(1):5. PubMed ID: 29310568
[TBL] [Abstract][Full Text] [Related]
12. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis.
Ford AC; Talley NJ; Spiegel BM; Foxx-Orenstein AE; Schiller L; Quigley EM; Moayyedi P
BMJ; 2008 Nov; 337():a2313. PubMed ID: 19008265
[TBL] [Abstract][Full Text] [Related]
13. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
Evans BW; Clark WK; Moore DJ; Whorwell PJ
Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
Didari T; Mozaffari S; Nikfar S; Abdollahi M
World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
[TBL] [Abstract][Full Text] [Related]
15. Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial.
Nee J; Ballou S; Kelley JM; Kaptchuk TJ; Hirsch W; Katon J; Cheng V; Rangan V; Lembo A; Iturrino J
Am J Gastroenterol; 2021 Nov; 116(11):2279-2285. PubMed ID: 34319275
[TBL] [Abstract][Full Text] [Related]
16. Acupuncture for treatment of irritable bowel syndrome.
Lim B; Manheimer E; Lao L; Ziea E; Wisniewski J; Liu J; Berman B
Cochrane Database Syst Rev; 2006 Oct; (4):CD005111. PubMed ID: 17054239
[TBL] [Abstract][Full Text] [Related]
17. Peppermint oil in irritable bowel syndrome.
Grigoleit HG; Grigoleit P
Phytomedicine; 2005 Aug; 12(8):601-6. PubMed ID: 16121521
[TBL] [Abstract][Full Text] [Related]
18. A trial-based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome.
Weerts ZZRM; Essers BAB; Jonkers DMAE; Willems JIA; Janssen DJPA; Witteman BJM; Clemens CHM; Westendorp A; Masclee AAM; Keszthelyi D
United European Gastroenterol J; 2021 Nov; 9(9):997-1006. PubMed ID: 34468079
[TBL] [Abstract][Full Text] [Related]
19. Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial.
Cappello G; Spezzaferro M; Grossi L; Manzoli L; Marzio L
Dig Liver Dis; 2007 Jun; 39(6):530-6. PubMed ID: 17420159
[TBL] [Abstract][Full Text] [Related]
20. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
Videlock EJ; Cheng V; Cremonini F
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]